surmount-1 trial tirzepatide obesity without diabetes weight loss Demonstrates 94% Reduction, 22% in SURMOUNT -1 Study In the SURMOUNT-5 phase 3b
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13

00377-2/asset/5849e908-c26a-472e-b460-1c99904b95c5/main.assets/gr2.jpg)


00656-2/asset/38c98550-9ec2-44e8-ba6a-dbb815075666/main.assets/gr1_lrg.jpg)


















